13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$770.08B
+8.1% on the quarter before
Positions
4,803
118 new · 213 sold out
Top 10
23.1%
of the value
Est. gain
+$46.72B
on stocks held all quarter
Est. return
+6.6%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 34% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$3.31BNew · 0.0% → 0.4%+9,335,306 shares
- GE HealthCare~$554.4MNew · 0.0% → 0.1%+6,775,612 shares
- Microsoft~$470.3MAdded · 4.8% → 5.4%+1,634,583 shares
- Apple~$398.4MAdded · 5.1% → 6.1%+2,421,295 shares
- Amazon~$388.9MAdded · 1.9% → 2.2%+3,774,390 shares
- Merck & Co. Inc.~$305.7MAdded · 0.8% → 0.7%+2,879,481 shares
- Paccar Inc~$298.6MAdded · 0.1% → 0.1%+4,082,677 shares
- Broadcom~$240.3MAdded · 0.6% → 0.6%+375,418 shares
- Tesla~$194.2MAdded · 0.8% → 1.3%+938,216 shares
- Berkshire Hathaway Inc-Cl B~$170.6MAdded · 1.4% → 1.3%+553,693 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$3.01BSold out · 0.4% → 0.0%−9,233,015 shares
- Svb Financial Group~$287.6MSold out · 0.0% → 0.0%−1,251,764 shares
- Meta~$258.1MCut · 0.8% → 1.2%−1,220,589 shares
- Philip Morris International~$239.7MCut · 0.4% → 0.4%−2,471,038 shares
- Canadian Pac Ry Ltd~$227.5MCut · 0.0% → 0.0%−2,957,073 shares
- Signature Bank~$157.5MSold out · 0.0% → 0.0%−1,369,231 shares
- Store Capital Corp~$130.9MSold out · 0.0% → 0.0%−4,082,272 shares
- Aon Plc-Class A~$125.7MCut · 0.2% → 0.1%−399,481 shares
- Lhc Group Inc~$91.0MSold out · 0.0% → 0.0%−562,826 shares
- Coupa Software Inc~$84.6MSold out · 0.0% → 0.0%−1,068,385 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.9% · price +26.9% | 6.1% | $46.92B | +$9.85B | ||||||||
| MicrosoftCOM · shares +1.1% · price +20.2% | 5.4% | $41.53B | +$6.89B | ||||||||
| AmazonCOM · shares +2.3% · price +22.9% | 2.2% | $17.03B | +$3.10B | ||||||||
| NvidiaCOM · shares +0.6% · price +90.0% | 1.7% | $12.76B | +$6.01B | ||||||||
| AlphabetCAP STK CL A · shares +1.3% · price +17.5% | 1.6% | $12.27B | +$1.81B | ||||||||
| TeslaCOM · shares +1.9% · price +68.3% | 1.3% | $10.36B | +$4.13B | ||||||||
| AlphabetCAP STK CL C · shares −0.1% · price +17.1% | 1.3% | $10.10B | +$1.48B | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares +1.8% · price −0.1% | 1.3% | $9.81B | −$9.0M | ||||||||
| MetaCL A · shares −2.7% · price +76.0% | 1.2% | $9.29B | +$4.01B | ||||||||
| Exxon Mobil CorpCOM · shares +0.7% · price −0.6% | 1.0% | $8.08B | −$50.9M | ||||||||
| Unitedhealth Group IncCOM · shares +1.4% · price −10.9% | 1.0% | $8.06B | −$972.9M | ||||||||
| Johnson & JohnsonCOM · shares +1.6% · price −12.3% | 0.98% | $7.53B | −$1.04B | ||||||||
| Visa Inc.COM CL A · shares +0.00% · price +8.5% | 0.94% | $7.25B | +$566.1M | ||||||||
| Procter & Gamble Co/TheCOM · shares +1.1% · price −2.0% | 0.90% | $6.94B | −$137.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.1% · price −2.9% | 0.88% | $6.80B | −$196.4M | ||||||||
| MastercardCL A · shares +0.4% · price +4.5% | 0.77% | $5.94B | +$252.5M | ||||||||
| Home Depot IncCOM · shares +0.7% · price −6.6% | 0.73% | $5.64B | −$396.0M | ||||||||
| Merck & Co. Inc.COM · shares +6.0% · price −4.1% | 0.71% | $5.44B | −$222.1M | ||||||||
| Abbvie IncCOM · shares +0.9% · price −1.4% | 0.70% | $5.41B | −$77.9M | ||||||||
| Chevron CorpCOM · shares −0.3% · price −9.2% | 0.69% | $5.31B | −$537.7M | ||||||||
| Eli LillyCOM · shares +1.1% · price −6.2% | 0.66% | $5.09B | −$331.1M | ||||||||
| BroadcomCOM · shares +5.0% · price +14.7% | 0.65% | $5.00B | +$609.7M | ||||||||
| Coca-Cola Co/TheCOM · shares +1.4% · price −2.6% | 0.62% | $4.76B | −$122.9M | ||||||||
| Pepsico IncCOM · shares +1.9% · price +0.9% | 0.62% | $4.75B | +$40.0M | ||||||||
| Pfizer IncCOM · shares +0.5% · price −20.4% | 0.58% | $4.47B | −$1.14B | ||||||||
| Total · 4,803 positions | 100% | $770.08B | +$46.72B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 4,682 stocks held throughout, up $46.72B (+6.6%).
- Apple+$9.85B+27%
- Microsoft+$6.89B+20%
- Nvidia+$6.01B+90%
- Tesla+$4.13B+68%
- Meta+$4.01B+76%
- Bank Of America Corp−$559.0M−14%
- Schwab (Charles) Corp−$823.0M−37%
- Unitedhealth Group Inc−$972.9M−11%
- Johnson & Johnson−$1.04B−12%
- Pfizer Inc−$1.14B−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |